Showing results (21-30 of 32) with videos related to

Sort By:
Pageof 4
JAMA|February 7, 2023
Four-Year Visual Outcomes in the Protocol W Randomized Trial of Intravitreous Aflibercept for Prevention of Vision-Threatening Complications of Diabetic RetinopathyRaj K Maturi, Adam R Glassman, Kristin Josic, et al.
Ophthalmology. Retina|October 10, 2021
A Randomized Trial of Photobiomodulation Therapy for Center-Involved Diabetic Macular Edema with Good Visual Acuity (Protocol AE)Judy E Kim, Adam R Glassman, Kristin Josic, et al.
Ophthalmology|May 14, 2021
Pneumatic Vitreolysis with Perfluoropropane for Vitreomacular Traction with and without Macular Hole: DRCR Retina Network Protocols AG and AHClement K Chan, Calvin E Mein, Adam R Glassman, et al.
Ophthalmology Science|May 1, 2026
Oral Tonabersat Connexin-43 Modulator for Diabetic Macular Edema with Good Vision (DRCR Retina Network Protocol AN)Andrew J Barkmeier, Thu P Vu, Michael Elman, et al.
Science Translational Medicine|April 6, 2018
A bioengineered retinal pigment epithelial monolayer for advanced, dry age-related macular degenerationAmir H Kashani, Jane S Lebkowski, Firas M Rahhal, et al.
Ophthalmology|December 31, 2023
Long-term Follow-up of a Phase 1/2a Clinical Trial of a Stem Cell-Derived Bioengineered Retinal Pigment Epithelium Implant for Geographic AtrophyMark S Humayun, Dennis O Clegg, Margot S Dayan, et al.
Therapeutic Advances in Ophthalmology|July 14, 2025
Plain language summary of publication of the 48-week results from the PHOTON study: intravitreal aflibercept 8 mg for diabetic macular edemaDavid M Brown, David S Boyer, Diana V Do, et al.
Therapeutic Advances in Ophthalmology|July 6, 2026
Plain language summary of publication of the 96-week results from the PHOTON study: intravitreal aflibercept 8 mg for diabetic macular edemaDiana V Do, Charles C Wykoff, Sobha Sivaprasad, et al.
Translational Vision Science & Technology|October 6, 2021
One-Year Follow-Up in a Phase 1/2a Clinical Trial of an Allogeneic RPE Cell Bioengineered Implant for Advanced Dry Age-Related Macular DegenerationAmir H Kashani, Jane S Lebkowski, Firas M Rahhal, et al.
Stem Cell Reports|February 5, 2022
Survival of an HLA-mismatched, bioengineered RPE implant in dry age-related macular degenerationAmir H Kashani, Jane S Lebkowski, David R Hinton, et al.
Pageof 4